IOVA vs. ATAI
IOVA (Iovance Biotherapeutics, Inc.) and ATAI (Atai Life Sciences N.V.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, IOVA returned -28.82%/yr vs -14.26%/yr for ATAI. Their 0.38 correlation means their historical movements had little consistent relationship.
Performance
IOVA vs. ATAI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IOVA achieves a 49.08% return, which is significantly lower than ATAI's 75.55% return.
IOVA
- 1D
- -13.22%
- 1M
- -5.57%
- 6M
- 59.61%
- YTD
- 49.08%
- 1Y
- 51.87%
- 3Y*
- -17.28%
- 5Y*
- -28.82%
- 10Y*
- -7.29%
- ALL TIME*
- -18.60%
ATAI
- 1D
- 0.00%
- 1M
- 38.34%
- 6M
- 90.96%
- YTD
- 75.55%
- 1Y
- 72.18%
- 3Y*
- 51.86%
- 5Y*
- -14.26%
- 10Y*
- —
- ALL TIME*
- -18.92%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $95.05M | $137.83M | $67.37M | |
| $68.89M | $75.72M | $64.68M |
IOVA vs. ATAI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
IOVA Iovance Biotherapeutics, Inc. | 49.08% | -63.11% | -8.98% | 27.23% | -66.53% | -22.46% |
ATAI Atai Life Sciences N.V. | 75.55% | 207.52% | -5.67% | -46.99% | -65.14% | -63.67% |
Correlation
The correlation between IOVA and ATAI is 0.25, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.25 |
Correlation (3Y) Balances recent behavior with more history. | 0.35 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.39 |
Correlation (All Time) Calculated using the full available price history since Jun 18, 2021 | 0.38 |
The correlation between IOVA and ATAI shifts across timeframes, from 0.25 (1 year) to 0.39 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
IOVA:
$1.82B
ATAI:
$2.66B
IOVA:
-$0.89
ATAI:
-$2.50
IOVA:
5.65
ATAI:
546.93
IOVA:
2.36
ATAI:
12.92
IOVA:
$285.61M
ATAI:
$3.49M
IOVA:
$327.04M
ATAI:
$3.49M
IOVA:
-$325.45M
ATAI:
-$663.38M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IOVA vs. ATAI — Risk / Return Rank
IOVA
ATAI
IOVA vs. ATAI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Iovance Biotherapeutics, Inc. (IOVA) and Atai Life Sciences N.V. (ATAI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IOVA | ATAI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.31 | ||
| Sortino ratioReturn per unit of downside risk | -0.33 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.23 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | 1.50 | 1.57 | -0.07 |
| Martin ratioReturn relative to average drawdown | 2.64 | 2.43 | +0.21 |
Loading charts...
Drawdowns
IOVA vs. ATAI - Drawdown Comparison
The maximum IOVA drawdown since its inception was -99.37%, roughly equal to the maximum ATAI drawdown of -95.05%. Use the drawdown chart below to compare losses from any high point for IOVA and ATAI.
Loading charts...
Drawdown Indicators
| IOVA | ATAI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.37% | -95.05% | -4.32% |
Max Drawdown (1Y)Largest decline over 1 year | -39.00% | -48.06% | +9.06% |
Max Drawdown (3Y)Largest decline over 3 years | -90.50% | -59.23% | -31.27% |
Max Drawdown (5Y)Largest decline over 5 years | -93.99% | -94.17% | +0.18% |
Max Drawdown (10Y)Largest decline over 10 years | -96.84% | — | — |
Current DrawdownCurrent decline from peak | -97.44% | -65.81% | -31.63% |
Average DrawdownAverage peak-to-trough decline | -84.27% | -80.58% | -3.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.14% | 30.99% | -8.85% |
Volatility
IOVA vs. ATAI - Volatility Comparison
The current volatility for Iovance Biotherapeutics, Inc. (IOVA) is 30.69%, while Atai Life Sciences N.V. (ATAI) has a volatility of 33.68%. This indicates that IOVA experiences smaller price fluctuations and is considered to be less risky than ATAI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IOVA | ATAI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 30.69% | 33.68% | -2.99% |
Volatility (6M)Calculated over the trailing 6-month period | 66.41% | 61.09% | +5.32% |
Volatility (1Y)Calculated over the trailing 1-year period | 93.87% | 82.57% | +11.30% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 90.78% | 85.28% | +5.50% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 81.92% | 84.88% | -2.96% |
Dividends
IOVA vs. ATAI - Dividend Comparison
Neither IOVA nor ATAI has paid dividends to shareholders.
Financials
IOVA vs. ATAI - Financials Comparison
This section allows you to compare key financial metrics between Iovance Biotherapeutics, Inc. and Atai Life Sciences N.V.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
IOVA and ATAI have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ATAI has higher volatility (33.68%) compared to IOVA (30.69%). In terms of maximum drawdown, IOVA dropped -99.37% vs ATAI's -95.05%.
ATAI currently has the higher Sharpe Ratio (0.94 vs 0.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IOVA and ATAI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer